With new treatment protocols being tested around the country, there is some progress in treating Alzheimer’s. Whether it studies on the D vitamin or studies on Amyloid, a sticky brain protein which is thought to cause the disease, doctors are making efforts to figure out how to improve treatments.
With an aging population, Alzheimer becomes a top priority as it affects and shortens the lives for millions of Americans.
One such example is David Johnson, a 59-year-old Alzheimer patient, who knew he was going to be affected by the disease, after losing his father, six aunts, and uncles and a cousin to Alzheimer’s.
He was diagnosed with early Alzheimer’s in 2012. He expected to live between three and five years. He thought he was going to die. But he was lucky enough to find a clinical trial at Sacramento’s Sutter Neuroscience Institute which helped to slow down, perhaps even halt the disease.
Because the clinical trial lasts for five years, it is too soon for doctors at Sutter Health to say how Johnson is doing. His treatment involves solutions made with special antibodies and it seems to be working to some extent.
Brain scans show that the disease is not progressing. His treatment is only one of other hundreds of tests going on nationwide, focused on Alzheimer’s and dementia. Amyloid, a sticky protein that becomes attached to brain cells and leads to Alzheimer’s is the main ingredient of the new therapies – in a modified form. None of the therapies being tested now are FDA approved yet, but some are nearing their final stages and have yielded promising results, according to experts.
Doctor John Olichney believes that pretty soon we’ll be seeing an explosive development in Alzheimer’s treatments. The first therapy to stop the disease in its tracks is already showing promising results. A lot of work was done over 10 years, but scientists have finally come up with something that seems to slow the progress of the disease.
Over five million Americans struggle with Alzheimer’s which is the most dangerous type of dementia, one which destroys brain cells. This makes it the sixth cause of death in American adults.
If no treatment is found, an aging population will lead to the increase in Alzheimer’s patients to 13.8 million in 2050.
Image Source – aam.govst.edu